Grace Therapeutics, Inc.

GRCE

—

Advanced chart & tools →

Grace Therapeutics, Inc.GRCE

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-0.79

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$100.00M

Net income

$-9.57M

Net margin

-9.6%

Gross margin

—

Dividends & financials

Grace Therapeutics, Inc. (GRCE) reported revenue of $100.00M and net income of $-9.57M, or $-0.79 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.